Wang Xiaolin sold RVMD
March 17, 2026 · Form 4 insider transaction
Wang Xiaolin sold 2,010 shares of Revolution Medicines, Inc. at $99.48 per share, a transaction worth $200.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,010
Price
$99.48
Total value
$200.0K
InsiderWang Xiaolin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after116,063
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on November 17, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after December 15, 2025.; Includes 48,700 RSUs.